Medicinal Chemistry Apr 2026

Learn about BMS-986165 , a highly selective inhibitor for autoimmune diseases. Unlike traditional drugs that compete for energy (ATP) sites, this "allosteric" approach targets a different part of the protein for better precision. Read more on PMC .

Instead of just blocking a protein, researchers are now creating molecules that "mark" disease-causing proteins for destruction by the cell's own waste system. A recent breakthrough includes a highly potent ENL degrader for treating acute myeloid leukemia. Explore the details at ACS Publications . Medicinal Chemistry

With antibiotic resistance rising, the discovery of BT-33 —a fully synthetic antibiotic that targets the bacterial ribosome—is a major milestone in chemical synthesis. Find it in Nature . 🔬 Emerging Trends to Watch Learn about BMS-986165 , a highly selective inhibitor

Medicinal chemistry is currently entering a "post-Rule of 5" era where researchers are designing complex molecules that were once thought impossible to create. Depending on your interest level, here are some of the most compelling recent articles and themes in the field: 🧪 Cutting-Edge Research Highlights Instead of just blocking a protein, researchers are

If you want to stay updated on the latest milestones, these journals are the gold standard: Journal of Medicinal Chemistry - ACS Publications

Traditional drugs usually follow certain "rules" (like size and solubility), but new complex targets require larger, more flexible molecules that are rewriting the textbook.

Artificial intelligence is now being used to predict protein structures and design new macrocyclic and covalent frameworks, transforming how we "program" molecules.